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Introduction
The loss of functional adenomatous polyposis coli (APC) is an 
early event in the development of most polyploid colorectal 
cancers (Kinzler and Vogelstein, 1996; Polakis, 1997). Mutated 
APC has been linked to genetic instability, which is an early 
hallmark of colorectal tumors and a factor that greatly promotes 
tumor development (Fodde et al., 2001; Kaplan et al., 2001; 
Shih et al., 2001). Exactly how APC is involved in maintaining 
chromosomal stability remains unknown. APC performs multi-
ple roles, including negative regulation of the Wnt signaling 
pathway (Bienz and Clevers, 2000; Polakis, 2000), organization 
of the cytoskeleton, and regulation of cell migration (Dikovskaya 
et al., 2001; Zumbrunn et al., 2001; Hanson and Miller, 2005; 
Nathke, 2005). This functional diversity places APC in an 
  important position in maintaining gut epithelia, but it is not 
clear how it relates to the function of APC in safeguarding a 
normal karyotype.
The formation of a protein complex between APC and the 
spindle assembly checkpoint proteins Bub1 and BubR1 and the 
ability of these kinases to phosphorylate APC in vitro (Kaplan 
et al., 2001) raise the intriguing possibility that APC “talks” 
  directly to the mitotic checkpoint machinery. Insuffi  cient 
  microtubule plus end attachment resulting from the expression 
of dominant, truncated fragments of APC inhibits chromosome 
congression at metaphase and results in abnormal chromosome 
segregation (Green and Kaplan, 2003; Green et al., 2005). 
  Consequently, the overexpression of N-terminal APC fragments 
(like those commonly found in tumors) in cells with wild-type 
APC can lead to premature exit from mitosis and aneuploidy 
(Tighe et al., 2004).
The loss of heterozygosity in the APC locus, which initi-
ates most colorectal tumors, has two direct consequences: the 
loss of normal functional APC and the expression of a truncated 
N-terminal APC fragment. It is likely that both the absence of 
functional APC and the presence of N-terminal APC fragments 
contribute in separate but interactive ways to the phenotype of 
APC-defi  cient cancers. The majority of previous work exam-
ined the dominant effects of N-terminal APC fragments com-
monly found in tumors (Green and Kaplan, 2003; Tighe et al., 
2004; Green et al., 2005). In most cases, the effects of N-terminal 
fragments were assessed in cells that, unlike tumors, also 
  express wild-type, full-length APC. The interpretation of these 
data requires an understanding of the effects produced by the 
absence of APC in order to distinguish the effects of N-terminal 
APC fragments from the effects that result from loss of APC 
 itself.  Therefore,  we  specifi  cally addressed the role of the 
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M
utations in the adenomatous polyposis coli (APC) 
tumor suppressor gene initiate a majority of 
colorectal cancers. Acquisition of chromosomal 
instability is an early event in these tumors. We provide evi-
dence that the loss of APC leads to a partial loss of inter-
kinetochore tension at metaphase and alters mitotic 
progression. Furthermore, we show that inhibition of APC 
in U2OS cells compromises the mitotic spindle checkpoint. 
This is accompanied by a decrease in the association of the 
checkpoint proteins Bub1 and BubR1 with kinetochores. 
Additionally, APC depletion reduced apoptosis. As ex-
pected from this combination of defects, tetraploidy and 
polyploidy are consequences of APC inhibition in vitro and 
in vivo. The removal of APC produced the same defects in 
HCT116 cells that have constitutively active β-catenin. 
These data show that the loss of APC immediately induces 
chromosomal instability as a result of a combination of mi-
totic and apoptotic defects. We suggest that these defects 
amplify each other to increase the incidence of tetra- and 
polyploidy in early stages of tumorigenesis.
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full-length APC molecule by depleting full-length APC in 
  several different systems.
Using Xenopus laevis egg extracts, we previously showed 
that lack of APC causes mitotic spindles to have several defects, 
including a disorganized microtubule network with reduced 
  total microtubule mass, particularly in the midspindle area 
(Dikovskaya et al., 2004). In the present study, we show that in 
addition to spindle defects, the mitotic spindle assembly check-
point is not functioning properly in cells lacking APC. Conse-
quently, we fi  nd that the loss of APC leads to the accumulation 
of tetraploid cells. Additionally, we observed decreased apopto-
sis in APC-defi  cient cells. We propose that this combination of 
defects can aid in the longevity of cells with abnormal DNA 
content to promote polyploidy. Importantly, we provide direct 
evidence for the appearance of tetra- and polyploid cells 
  extremely early after APC is inactivated not only in cultured 
cells but also in gut tissue. Additionally, we eliminate a major 
role for β-catenin signaling in the observed effects by showing 
identical defects in HCT116 cells, which carry an activating 
mutation in β-catenin.
Results
Lack of APC leads to reduced tension 
at kinetochores metaphase
To address how the lack of APC affects mitotic spindle function 
in cells, we removed APC from human osteosarcoma U2OS cells 
using RNAi. Transfection of 5 nM siRNA targeting APC reduced 
the level of APC protein to 14.7 ± 8.6% of that in cells trans-
fected with nontargeting control siRNA (Fig. 1 A). The increase 
in β-catenin in cells treated with anti-APC siRNA further con-
fi  rmed the reduction of functional APC in such cells (Fig. 1 A).
Mitotic spindles in cells lacking APC were not grossly 
perturbed. However, the inability of such spindles to create full 
tension at kinetochores showed compromised spindle function 
(Fig. 1 B). The distance between sister kinetochores in pro-
phase, when there is no bipolar attachment and therefore no ten-
sion, was almost identical in APC-inhibited and control cells 
(0.74 ± 0.03 μm and 0.70 ± 0.03 μm [mean ± SEM], respec-
tively). In control cells, the distance between sister kinetochores 
increased to 1.38 ± 0.02 μm in metaphase, indicating the devel-
opment of tension. Notably, interkinetochore distance in meta-
phase chromosomes of APC-defi  cient cells only reached 1.15 ± 
0.02 μm, which is signifi  cantly different (P < 0.001; Mann-
Whitney rank sum test and t test) from the control metaphase 
dataset. This demonstrates that metaphase kinetochores in APC-
defi  cient spindles were under reduced tension.
In mouse fi  broblasts in which APC expression can be 
conditionally inactivated (Sansom et al., 2004), APC removal 
produced the same effect (Fig. S1, available at http://www.
jcb.org/cgi/content/full/jcb.200610099/DC1). Thus, the loss of 
APC leads to defects in the mitotic spindle that are translated 
into reduced tension on metaphase kinetochores.
Loss of APC correlates with reduced Bub1 
at kinetochores
Insuffi   cient interkinetochore tension induced by APC loss 
should lead to the accumulation of mitotic checkpoint proteins 
Figure 1.  Mitotic defects in APC-deﬁ  cient cells. (A) A 
reduction in the amount of APC protein in U2OS cells 
using RNAi. Lysates from U2OS cells transfected with 
short RNA duplexes directed against APC or with con-
trol RNA duplexes were collected 72 h after transfection. 
Proteins were separated by PAGE and probed for 
APC, β-catenin, and actin (loading control). (B) Tension 
between kinetochores of metaphase sister chromatids 
is reduced in APC-deﬁ   cient U2OS cells. Interkineto-
chore distances in U2OS cells transfected with non-
targeting (iC) or APC-targeting (iA) siRNA as in A were 
measured as the distances between CREST-stained 
  kinetochores in prophase or metaphase chromosomes 
as indicated. Mean values are shown as red bars. 
(C) APC inhibition in U2OS cells decreases the time 
from mitotic entry to anaphase onset. U2OS cells 
transfected with control (iC) or APC-targeting (iA) 
siRNA together with H2B-RFP were presynchronized 
by a single thymidine block and released for 6 h 
  before imaging their mitotic progression for 6 h. Time 
from initiation of mitosis to anaphase onset was mea-
sured for 14 control and 32 APC-deﬁ  cient cells and is 
shown as box plots using a ﬁ  ve-point summary. Pairs 
with a statistically signiﬁ  cant difference (P < 0.005) in 
two-tailed  t tests are indicated by red hashes (#). 
(D and E) Reducing APC causes a mitotic checkpoint 
defect. U2OS cells transfected for 52 h with control or 
APC-directed siRNA duplexes were incubated with 
  increasing amounts of nocodazole (A) or taxol (B) for 
a further 20 h before staining with propidium iodide 
and antiphosphohistone H3 antibodies. Mitotic index 
was determined by ﬂ  ow cytometry and is shown as 
the percentage of live cells that were phosphohistone 
H3 positive and had high ( 4n) DNA content. Data 
are represented as the mean ± SD (error bars).HOW LOSS OF APC LEADS TO POLYPLOIDY • DIKOVSKAYA ET AL. 185
like Bub1 and BubR1 on kinetochores. Therefore, we quanti-
tated the amount of kinetochore-associated Bub1 and BubR1 in 
APC-defi  cient and control mitotic cells by measuring the inten-
sities of Bub1 and BubR1 immunofl  uorescence at kinetochores, 
which were defi  ned by costaining with CREST (Fig. 2 A; also 
see Materials and methods; Schiffmann et al., 2006). Bub1 and 
BubR1 accumulate at kinetochores at prophase and gradually 
disappear throughout mitosis, with only minimal kinetochore 
localization at metaphase and anaphase (Jablonski et al., 1998; 
Howell et al., 2004). Our measurements confi  rmed these dy-
namics of Bub1 and BubR1 at kinetochores (Fig. 2, B and C). 
However, despite insuffi  cient tension at kinetochores, unsyn-
chronized U2OS cells transfected with APC-targeting siRNA 
accumulated 1.84-fold less Bub1 per cell (mean reduced by 
45.6%, which is signifi  cant; P < 0.001 in a two-tailed t test) 
and 1.66-fold less BubR1 (mean reduced by 39.7%, which is 
signifi  cant; P < 0.01 in a two-tailed t test) at kinetochores during 
prometaphase than cells transfected with control siRNA (Fig. 
2, B and C). The difference was still detectable at the prometa-
phase→metaphase transition and in metaphase cells; however, 
it was not statistically signifi  cant at these stages.
We also used fi  broblasts from mice with constitutively re-
duced APC protein (Kaplan et al., 2001) and compared them 
with fi  broblasts isolated from wild-type littermates (Fig. 2 D). 
Again, we found that APC-defi  cient cells had less Bub1 and 
BubR1 at kinetochores than control cells (Fig. 2, E and F). In 
prometaphase, the mean kinetochore-associated Bub1 intensity 
per cell in APC-defi  cient  fi   broblasts was reduced 1.65-fold 
(39.3% of that in wild-type cells, which is signifi  cant; P < 0.05 
in a two-tailed t test; mean kinetochore-associated BubR1 per 
cell was reduced 2.37-fold [58.3% of wild-type counterpart], 
which is signifi  cant; P < 0.001 in a two-tailed t test). Thus, two 
Figure 2.  Reduction in kinetochore-associ-
ated Bub1 and BubR1 in APC-deﬁ  cient cells. 
(A) Examples of cells stained with antibodies 
against the kinetochore marker CREST, Bub1, 
and BubR1, which were used to measure 
  kinetochore-associated Bub1 and BubR1. 
U2OS cells were ﬁ  xed and stained with DAPI, 
anti-CREST, anti-Bub1, and anti-BubR1 antibod-
ies as indicated. Each image represents a pro-
jection of several 0.2-μm sections. Insets show 
magniﬁ  ed regions of the image (indicated in 
the CREST image; arrow); a circle in the insets 
indicates the region identiﬁ  ed by CREST staining 
that was then used as the kinetochore domain 
to calculate the amount of Bub1 or BubR1 
intensity at this site. Bars, 5 μm. (B and C) 
The relative amount of Bub1 (B) and BubR1 
(C) at mitotic kinetochores of U2OS cells de-
creases after APC depletion. Cells treated with 
control (white) or APC-targeted (gray) siRNA 
as in Fig. 1 A were ﬁ  xed and stained as in 
A (this ﬁ  gure). The total intensity of Bub1 and 
BubR1 at kinetochores was measured in 3D 
images of individual cells using the OME 
  system optimized for high throughput analy-
sis as described in Materials and methods. 
Box plots show the amount of kinetochore-
  associated Bub1 and BubR1 per cell normal-
ized to the amount of CREST in this region 
using a ﬁ  ve-point summary. For each box plot, 
the number of cells on which it was based is 
indicated below the x axis. (D) Immunoblot of 
a constitutive APC mutant (∆APC) and wild-
type (wt) counterpart mouse ﬁ  broblasts  with 
anti-APC antibodies reveals the reduced level 
of APC in mutant ﬁ  broblasts. Actin was used 
as a loading control. (E and F) APC-deﬁ  cient 
(∆APC; gray) and wild-type (wt; white) ﬁ  bro-
blasts were prepared as in A, and the amount 
of Bub1 (E) or BubR1 (F) at kinetochores was 
quantitated as in B and C, with the difference 
that Bub1- and BubR1-stained cells were col-
lected in separate datasets rather than from 
the same cells. APC-deﬁ  cient cells accumulate 
relatively less Bub1 and BubR1 at their kineto-
chores during mitosis, particularly during pro-
metaphase. Pairs with a statistically signiﬁ  cant 
difference in two-tailed t tests are indicated by 
red hashes (#). B, P < 0.001; C, P < 0.01; 
E, P < 0.05; F, P < 0.001. Mild outliers are 
indicated by circles, and extreme outliers are 
shown by asterisks.JCB • VOLUME 176 • NUMBER 2 • 2007  186
independent APC-defi  cient cell systems showed a decrease in 
the amount of both Bub1 and BubR1 at kinetochores.
Effect of APC inhibition on mitotic 
progression
Monitoring the mitotic progression of logarithmically growing 
APC-inhibited and control U2OS cells revealed that inhibiting 
APC resulted in a decrease in the time from entry into mitosis to 
the onset of anaphase (27.9 ± 1.1 min in control and 23.3 ± 0.6 
min in APC-inhibited cells), which was statistically signifi  cant 
(P < 0.005 by a Mann-Whitney rank sum test; Fig. 1 C).
Thus, APC inhibition resulted in the loss of both check-
point proteins at kinetochores despite decreased interkineto-
chore tension. This correlated with a decrease in the time to 
anaphase onset in APC-negative cells. Together, these data indi-
cate that in addition to spindle damage, the mitotic checkpoint 
might be compromised by APC removal.
APC inhibition leads to a defective mitotic 
spindle checkpoint
To assess mitotic checkpoint function, we treated cells with micro-
tubule poisons that induce mitotic arrest if the mitotic spindle 
checkpoint is intact and counted phosphohistone H3–positive 
cells. Histone H3 is specifi  cally phosphorylated in mitosis 
(Hendzel et al., 1997), and this event is commonly used as a 
marker for mitotic cells.
We observed that in U2OS cells, both nocodazole and 
taxol treatment led to a dose-dependent accumulation of cells 
in mitosis (Fig. 1, D and E; iContr). Inhibition of APC repro-
ducibly resulted in a reduction in the number of mitotically 
arrested cells after 20 h of treatment with a broad range of 
concentrations of both taxol and nocodazole compared with 
cells transfected with control nontargeting siRNA (Fig. 1, D 
and E). This was not caused by a G2 block or delay, which 
would prevent cells from entering mitosis, as G2 progression 
in presynchronized cells was not altered by APC removal 
(Fig. S2, available at http://www.jcb.org/cgi/content/full/
jcb.200610099/DC1). Thus, APC inhibition does not com-
pletely obliterate but substantially compromises the mitotic 
checkpoint in U2OS cells.
Inhibiting APC increases mitotic slippage
One of the consequences of a damaged mitotic checkpoint is 
the inappropriate exit of cells from mitosis into G1 to produce 
tetraploid cells. To distinguish cells that had exited mitosis 
with a 4n DNA content from the rest of the 4n DNA popula-
tion, representing a mixture of cells in G2 and M, we costained 
cells with 7AAD (for DNA profi  le) and FITC-labeled anti–
cyclin B1 antibody (Fig. 3 A). The cyclin B1 level is lowest 
in G1, gradually accumulates throughout S and G2, and peaks 
in mitosis (Hwang et al., 1995). Thus, the 4n DNA/cyclin 
B1–negative population (Fig. 3 A, red) represents cells that 
inappropriately exited mitosis with double chromosome 
content. This population was clearly increased in APC-defi  cient 
cultures even in the absence of mitotic poisons (Fig. 3, A and B). 
Mitotic arrest induced by taxol or nocodazole increased the 
number of 4n DNA/cyclin B1–negative cells. Importantly, such 
tetraplolid G1 cells were 1.5–2 times more abundant after APC 
depletion (Fig. 3 B).
Comparing cyclin B1 profi  les for control and APC-negative 
cells arrested by taxol after synchronization (see Fig. S2 A for 
protocol) revealed a massive degradation of cyclin B1 in 
APC-negative cells when the level of cyclin B1 in control cells 
was only slightly decreased (Fig. 3 C). Thus, premature cyclin 
B1 degradation is likely to be involved in the increased mitotic 
slippage of APC-defi  cient cells.
Figure 3.  Inhibiting APC causes mitotic slippage and tetraploidy. (A) Flow 
cytometry proﬁ  les of cells 3 d after transfection with control (iContr) or APC-
directed (iAPC) siRNA stained with FITC-labeled anti–cyclin B1 antibodies 
and 7AAD to detect DNA content. The 4n DNA cyclin B1–negative popu-
lation representing tetraploid cells in G1 is shown in red; the polyploid 
population (>4n DNA) falls into the area shaded in blue. (B) APC inhibi-
tion leads to an increase in the number of tetraploid cells. The proportion 
of cells with a 4n DNA content that were cyclin B1 negative (tetraploid G1) 
in the total live cell population of U2OS cells was measured in cells 3 d 
  after transfection with control or APC-targeting siRNA and, where indicated, 
after 20 h of treatment with 1.25 μg/ml taxol or nocodazole before har-
vesting and staining as in A. (C) Premature cyclin B degradation in mitoti-
cally arrested APC-deﬁ  cient cells. Control (iContr) and APC-deﬁ  cient (iAPC) 
U2OS cells were synchronized by double thymidine block and released 
into 1.25 μg/ml taxol (as outlined in Fig. S2 A, available at http://www.
jcb.org/cgi/content/full/jcb.200610099/DC1). Cells were collected at 
the indicated times after the addition of taxol and were stained as in A. The 
loss of cyclin B1 in APC-deﬁ  cient cells 25.5 h after arrest is indicated by an 
arrow. (B and C) Data are represented as the mean ± SD (error bars).HOW LOSS OF APC LEADS TO POLYPLOIDY • DIKOVSKAYA ET AL. 187
APC removal alters exit 
from drug-induced mitosis
To determine the fate of APC-defi  cient cells that exit mitosis 
prematurely, we imaged U2OS cells expressing H2B–red fl  uo-
rescent protein (RFP). H2B-RFP localizes to chromatin at all 
times, making it possible to observe chromatin structures 
in vivo. Observation of control (n = 175) and APC-inhibited (n = 
172) cells arrested in taxol for 20 h revealed several differences 
between these cells. First, we found that as expected, APC inhi-
bition shortened the time that cells remained arrested in mitosis 
(Fig. 4 C). The number of cells arrested for >10 h was 25% 
lower when APC was inhibited (88% of all mitoses in control 
and 66% in APC-defi  cient cells), and the number of cells 
  arrested in mitosis for >15 h was halved by APC inhibition (52% 
in control and 27% in APC-defi  cient cells). This confi  rmed that 
the loss of APC induces spindle checkpoint defects.
Second, careful monitoring of cells revealed two types 
of mitotic exit. One type (Fig. 4 A) was accompanied by 
  prolonged membrane blebbing that coincided with mild chro-
mosomal   decondensation and was followed by the tightening 
and fragmentation of chromatin, which are typical signs of 
apoptosis. Eventually, such a cell acquired an irregular shape, 
lost all movements, and fl  oated (Fig. 4 A, bottom). The second 
typeof mitotic exit (Fig. 4 B) displayed mild, if any, membrane 
Figure 4.  Visualization of mitotic slippage in APC-
deﬁ  cient cells arrested with taxol. (A) Representative 
images of control siRNA-treated U2OS cells showing 
mitotic arrest followed by cell death. 2 d after cotrans-
fection with H2B-RFP and siRNA, cells were treated 
with 1.25 μg/ml taxol. Mitotic arrest was followed by 
the imaging of ﬂ  uorescent chromatin-associated H2B 
(right) or brightﬁ  eld (left) for 19 h starting 1 h after 
taxol addition. Both entry and exit from mitotic arrest 
are depicted as well as images of cells at the end of 
the recording (end). Note the membrane blebbing, 
chromatin tightening, and fragmentation as well as 
the change in the cell shape at the end of mitotic exit. 
(B) Representative image of a U2OS cell treated with 
APC-targeting siRNA that spreads after mitotic arrest. 
Cells were treated and imaged as in A. Images 
of control and APC-deﬁ   cient cells were collected in 
parallel. Mitotic entry and mitotic exit of an APC-inhibited 
cell are depicted using both brightﬁ  eld (left) and ﬂ  uo-
rescent chromatin (right) images at the indicated times 
as well as ﬂ  uorescent images of ﬁ  nal chromatin struc-
ture at the end of the video. Note the chromatin 
  decondensation (most apparent at 2 h and 0 min), cell 
spreading, and irregular chromatin structure at the 
end of mitotic exit. (C) Taxol-induced mitotic arrest is 
shortened by APC inhibition. U2OS cells were treated 
and imaged as in A, and the times of mitotic entry (as 
judged by rounding up or/and chromatin condensa-
tion) and exit (as judged by membrane blebbing or/
and chromatin decondensation) were recorded for 
each individual cell. The graph shows the percentage 
of control (blue) and APC-inhibited (pink) cells that re-
mained in mitosis for longer than the indicated times. 
175 control and 172 APC-deﬁ   cient cells were 
  analyzed. (D) An example of chromatin structure in 
  interphase APC-deﬁ  cient U2OS cells. 3 d after APC 
inhibition by siRNA, U2OS cells were ﬁ  xed  and 
stained with DAPI. The image represents a projection 
of several 0.2-μm sections. Bar, 15 μm. (E) Proportion 
of different types of mitotic exit in APC-deﬁ  cient and 
control U2OS cells. Cells were treated and imaged as 
in A–C, and the number of cells that spread after exit-
ing mitosis (purple; as in B) and that did not spread 
  after exiting mitosis (pink; as in A) were counted and 
plotted to show the proportion of each type of mitotic 
exit. (F) An example of a taxol-arrested APC-deﬁ  cient 
cell that attempts to form a cleavage furrow (black 
  arrow in brightﬁ  eld image; left) and in which the chro-
matin is stretched (white arrow; right), as if the cell is 
attempting to divide. After this event, the chromatin 
decondensed, indicating mitotic exit.JCB • VOLUME 176 • NUMBER 2 • 2007  188
blebbing but slight and short waves of cell reshaping. This 
coincided with chromatin decondensation and was followed by 
cell spreading. After cell spreading, decondensed chromatin 
remained partially fragmented for some time and contained 
holes that were gradually sealed (Fig. 4 B, bottom). This pheno-
type suggested that cells exited mitosis with a 4n DNA content 
and remained alive. Note that even in the absence of mitotic 
poison, we frequently observed misshapen interphase chromatin 
in APC-defi  cient cultures that could be the result of such alternative 
mitotic exit (Fig. 4 D). Quantitating these types of mitotic exit 
in control and APC-defi  cient cells revealed striking differences 
(Fig. 4 E). APC-defi  cient cells exited mitosis by the second 
route (spreading) twice as often as control cells, with 85% of 
APC-negative cells exiting in this manner, whereas only 41% of 
control cells spread after mitotic exit. Additionally, in a few 
cases, APC-defi  cient cells that spread after exiting mitosis initiated 
furrow formation and chromosome stretching (Fig. 4 F) despite 
the presence of taxol, which prevented spindle function.
Inhibition of APC decreases apoptosis
The prevalence of cell spreading as a route of mitotic exit in 
APC-negative cells suggested that these cells survived taxol 
treatment better than control cells. Therefore, we asked whether 
APC inhibition altered apoptotic response to microtubule poi-
sons. Consistent with this idea, we found that inhibiting APC 
invariably decreased the relative size of the sub-G1 DNA frac-
tion, which is an indicator of apoptosis (Fig. 5, A and B). This 
was true for both untreated cells and cells treated with taxol at 
various concentrations and for different amounts of time (10 h 
in Fig. 5 A and 20 h in Fig. 5 B).
To measure apoptosis directly in APC-negative cells, we 
stained cells with fl  uorescently labeled antibody directed against 
the cleaved version of caspase 3 that is specifi  c for cells in apopto-
sis and counted the number of cells positive for active caspase 3 
using fl  ow cytometry (Fig. 5 C, R2 area). All APC-negative 
cells described here, constitutively APC-defi  cient mouse fi  bro-
blasts (Fig. 5 C, top), anti-APC siRNA-treated U2OS cells (Fig. 
5 C, bottom), and mouse fi  broblasts with conditionally inacti-
vated APC (Fig. S1) responded to staurosporine with a dramatic 
increase in the number of apoptotic cells. These data validated 
the antiactive caspase 3 antibody as a useful tool to detect apop-
tosis in these cells and indicated that the apoptotic machinery is 
generally functional in the absence of APC. Using this method, 
we found that inhibiting APC reduced apoptosis in untreated 
and nocodazole- or taxol-treated U2OS cells (Fig. 5 D). In 
  addition, the baseline level of apoptosis in mouse fi  broblasts 
that are constitutively defi  cient for APC (∆APC) was reduced in 
comparison with that in the wild-type control cells (Fig. 5 E). 
Decreased apoptotic response to virus treatment was also 
  detected in fi  broblasts in which APC expression was condi-
tionally inactivated (Fig. S1). Together, these results show that 
  inhibiting APC results in a decrease in apoptosis.
Inhibiting APC leads to polyploidy
Tetraploid cells are often eliminated by apoptosis (Blajeski et al., 
2001; Rieder and Maiato, 2004), and failure to do so would 
  allow such cells to progress to polyploidy. The relative number 
Figure 5.  The loss of APC inhibits apoptosis. (A) U2OS cells transfected 
with nontargeting (iCONTR) or APC-targeting (iAPC) siRNA were treated 
with no or increasing amounts of taxol for 10 h. They were ethanol ﬁ  xed 
and stained with propidium iodide to measure their DNA proﬁ  les by ﬂ  ow 
cytometry. The fraction of cells with sub-G1 DNA content, which is an indi-
cator of apoptosis, is shown as a percentage of the total number of cells. 
(B) U2OS cells transfected with nontargeting (iContr) or APC-targeting 
(iAPC) siRNA were treated with 1.25 μg/ml taxol for 20 h, and the sub-G1 
fraction was measured as in A. (C) APC-deﬁ  cient cells can apoptose. 
Mouse ﬁ  broblasts constitutively lacking APC (∆APC ﬁ  broblasts; see Fig. 2 D 
for Western blot) or U2OS cells treated with APC-targeting siRNA (U2OS + 
siAPC) were treated for 12 h with 0.1 μM staurosporine (right) or were 
left untreated (left). Cells were ﬁ  xed and stained with PE-labeled antibody 
against active (cleaved) caspase 3 and analyzed by ﬂ  ow cytometry. Cells 
positive for active caspase 3 fall into polygon R2. The percentage of active 
caspase 3–positive (apoptotic) cells is indicated in the right top corner of 
each dot blot. Note a dramatic increase in apoptosis after staurosporine 
treatment in all APC-deﬁ   cient cells. (D) U2OS cells transfected with 
  nontargeting (iContr) or APC-targeting (iAPC) siRNA were treated with 
1.25 μg/ml nocodazole (noc) or taxol (tax) for 20 h or were left untreated 
(no), were stained with PE-labeled antiactive caspase 3 antibody, and were 
analyzed as in C. Bars show the percentage of apoptotic (active caspase 3 
positive) cells. (E) Constitutively APC-deﬁ  cient mouse ﬁ  broblasts (∆APC) 
and their wild-type counterpart (wt) were stained with PE-labeled antiactive 
caspase 3 antibody and were analyzed as in C. Bars show the percentage 
of apoptotic cells. (B and E) Data show a representative example of one out 
at least three independent experiments; for each experiment, duplicate 
samples were analyzed by ﬂ  ow cytometry. (B, D, and E) Data are represented 
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of polyploid cells (>4n DNA; Fig. 3 A, blue shaded area) was 
up to three times higher in APC-defi  cient than in control cul-
tures, which is consistent with the predicted consequence of 
an increased tetraploid G1 pool and decreased apoptosis. This 
was true for untreated or drug-treated cells (Fig. 6 A). Notably, 
deleting APC caused an overproportional increase in the num-
ber of polyploid cells relative to the increase in the tetraploid G1 
cells (Fig. 6 B; compare Figs. 3 B with 6 A), suggesting that rel-
atively more tetraploid cells proceeded to cycle. This is consis-
tent with an apoptotic defi  ciency in these cells and confi  rms that 
lack of APC promotes polyploidy.
Effect of APC inhibition in cells insensitive 
to 𝗃-catenin activation
The multifunctional nature of APC raises the question of the 
mechanism for APC control of mitotic progression. To discrimi-
nate between the effects of an increase in β-catenin signaling 
resulting from APC inhibition and possible direct contributions 
of the APC molecule to the mitotic checkpoint and apoptotic 
machinery, we analyzed the consequences of APC inhibition in 
HCT116 colon cancer cells. HCT116 cells have constitutively 
transcriptionally active β-catenin as a result of a mutation in 
one of their β-catenin alleles. Removing APC in these cells 
  allowed us to assess the direct role of APC independently of its 
β-catenin–mediated targets.
Using a β-catenin/T cell factor (TCF)–responsive pro-
moter element fused to luciferase (Morin et al., 1997) to mea-
sure the effect of APC inhibition on the activation of β-catenin 
signaling, we confi  rmed that in HCT116 cells, APC inhibition 
produced a minute effect (3.8× activation) on β-catenin–
  activated transcription compared with the massive (1,903×) 
activation in U2OS cells (Fig. S3, available at http://www.jcb.
org/cgi/content/full/jcb.200610099/DC1). If β-catenin/TCF 
  target genes make a major contribution to controlling mitotic 
progression, the effect of APC inhibition in HCT116 cells 
should be minimal.
However, APC inhibition in HCT116 cells resulted in 
quantitatively nearly identical phenotypical changes to those 
observed in U2OS cells. Mitotic index in both taxol- and 
  nocodazole-arrested HCT116 cells was decreased by APC 
Figure 6.  Loss of APC leads to polyploidy. (A) Control or APC-targeting 
siRNA-transfected U2OS cells were treated with 1.25 μg/ml taxol or 
  nocodazole for 20 h or were left untreated before harvesting and staining 
with FITC-labeled anti–cyclin B1 antibody and 7AAD for DNA content 
as in Fig. 3. The proportion of polyploid cells (>4n DNA; indicated as 
blue shaded area in Fig 3 A) in APC-positive (iContr) and APC-deﬁ  cient 
(iAPC) cultures was determined. Graph represents the percentage of poly-
ploid cells as the mean ± SD (error bars). (B) Accumulation of polyploid 
(>4n DNA) cells is accelerated in the absence of APC. U2OS cells were 
transfected with APC or control targeted siRNA, arrested, and stained as 
in A. The ratio of the polyploid population measured as in A to the tetra-
ploid G1 population measured as in Fig. 3 was calculated. The graph 
represents the mean of polyploid/tetraploid G1 ratios ± SD for APC-
  deﬁ  cient (iAPC) and control (iContr) U2OS cells, which were either unsyn-
chronized or treated with mitotic poisons as indicated. (A and B) Data 
show a representative example of one out at least three independent 
  experiments; for each experiment, duplicate samples were collected for 
ﬂ  ow cytometry analysis.
Figure 7.  Depleting APC affects the mitotic checkpoint and apoptosis and 
leads to tetra- and polyploidy in HCT116 cells. (A) HCT116 cells trans-
fected with control (ﬁ  rst lane) or APC-targeting (second lane) siRNA for 36 h 
were lysed, separated by PAGE, and blotted for APC and glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH; loading control). (B) APC inhi-
bition results in mitotic spindle checkpoint defects in HCT116 cells. HCT116 
cells were transfected with control (purple) or APC-targeting (pink) siRNA 
for 36 h and were either arrested with 10 ng/ml taxol or 100 ng/ml 
nocodazole for 12 h or were left untreated. Cells were harvested, ﬁ  xed, and 
stained with phosphohistone H3 antibody to detect mitotic cells. (C) The 
G1 tetraploid population is increased in APC-deﬁ  cient HCT116. HCT116 
cells transfected and treated as in B were harvested and stained for cyclin 
B1 and DNA content as in Fig. 3. (D) The polyploid population is in-
creased in APC-deﬁ  cient HCT116 cells. The graph represents the polyploid 
population in control (purple) and APC-deﬁ  cient HCT116 cells treated and 
stained as in C. (E) Apoptosis is decreased in APC-deﬁ  cient HCT116 cells. 
The sub-G1 fractions in control (purple) and APC-deﬁ  cient HCT116 cells 
treated and stained as in C are shown. (B–E) Values are given as the mean ± 
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inhibition (Fig. 7 B), indicating a mitotic spindle checkpoint 
defect. The relative size of both the tetraploid G1 and poly-
ploid populations were increased in mitotically arrested and 
unsynchronized HCT116 cells upon APC removal (Fig. 7, C 
and D).  Additionally, similar to results in U2OS cells, the 
sub-G1 fraction was decreased by APC depletion in unsyn-
chronized and taxol/nocodazole-treated HCT116 (Fig. 7 E), 
indicating apoptotic defi  ciency. Thus, the effects of APC on 
the mitotic checkpoint, apoptosis, and, consequently, on the 
loss of euploidy can be exerted independently of downstream 
targets of β-catenin.
Loss of APC induces tetraploidy in vivo
To test whether the loss of euploidy demonstrated by increased 
tetra- and polyploidy in APC-defi  cient cells in vitro was also 
detectable in vivo, we determined whether a similar phenomena 
occurred when APC was deleted from intestinal cells using 
Cre-lox technology. Mice bearing a lox/P-fl  anked APC and an 
inducible form of Cre-recombinase (AhCre
+Apc
fl  /fl  ) lose APC 
expression specifi  cally in the gut (Sansom et al., 2004) upon the 
induction of Cre-recombinase expression. At day 8 after Cre in-
duction, we observed a subset of cells within the AhCre
+Apc
fl  /fl   
intestine with up-regulated p21, a marker for the loss of 
euploidy (Fig. 8, A–D). This was apparent as early as 3 d after 
induction (Fig. 8 E). The average nuclear area of these cells at day 
3 (Fig. 8 F) or 8 (Fig. 8 G) showed an approximately twofold 
increase (P = 0.01; Kolmorov-Smirnov test), implying poly-
ploidy. To confi  rm ploidy changes in these cells, the DNA con-
tent of intestinal epithelium from induced Cre
+Apc
wt/wt and 
Cre
+Apc
fl  /fl   mice was examined at day 6 by fl  ow cytometry (Fig. 
8 H). In Cre
+Apc
wt/wt epithelium, only 0.63% of cells had a 
DNA content >4n, whereas 9.1% of cells extracted from 
Cre
+Apc
fl/fl mice had a >4n DNA content. Thus, the loss of 
  euploidy is also an early consequence of APC depletion in the 
intestinal epithelium.
Together, our data provide evidence that the loss of APC 
in several systems rapidly and directly leads to tetra- and poly-
ploidy both in vitro and in vivo. A combination of defects is 
likely to be responsible for this: fi  rst, abnormal spindles; sec-
ond, a compromised spindle assembly checkpoint; and, third, 
a decrease in apoptosis that allows inappropriate survival of 
  defective cells. We propose that incapacitating one single mole-
cule, APC, creates this unique combination of defects that leads 
to the simultaneous disruption of several layers of cellular con-
trol (Fig. 9) and, thus, provides a selective advantage for APC-
negative tumor cells. 
Figure 8.  Loss of APC leads to tetraploidy in vivo. (A–E) 
Immunohistochemistry on intestinal tissue sections from mice 
with inducible Cre-recombinase (AhCre
+) and wild-type APC 
(wt; A and C) and from AhCre
+ mice carrying ﬂ  oxed APC 
(APC
ﬂ  /ﬂ  ; APC mut; B, D, and E) 8 (A–D) or 3 d (E) after Cre in-
duction to inactivate APC in APC
ﬂ  /ﬂ   but not APC
wt/wt mice. 
Sections were stained for p21 and counterstained with hae-
matoxylin to outline nuclei. C and D are magniﬁ  cations of 
  areas in A and B, respectively. Note that only tissue from 
AhCre
+APC
ﬂ  /ﬂ  , when APC was lost, had up-regulated p21 in 
the epithelial cells in crypts. (F and G) The nuclear area of 
  epithelial cells in Cre-induced AhCre
+APC
wt/wt (wt/wt) or 
AhCre
+APC
ﬂ  /ﬂ   tissue that were p21 negative (ﬂ  /ﬂ   ) or p21 
positive (ﬂ  /ﬂ   p21 positive) were measured 3 (F) or 8 d (G) 
  after Cre induction. The median nuclear area in p21-positive 
cells is twice that of p21-negative cells in APC
ﬂ  /ﬂ   mice, sug-
gesting that the former cells are tetraploid. (H) Flow cytometric 
analysis of intestinal samples 6 d after the initiation of Cre-
mediated excision in AhCre
+APC
wt/wt (wt; top) and AhCre
+
APC
ﬂ  /ﬂ   (APC mut) mice shows an increase in the number of 
tetra- and polyploid cells in tissue without APC. (I) A tumor 
from the intestine of an APC
min mouse. Sections are counter-
stained with β-catenin, which is up-regulated in tumors. The 
arrow and arrowhead indicate the position of adenomas with 
high β-catenin levels. Note that nuclei showing a strong signal 
for β-catenin are larger than those in the surrounding tissue 
(inset shows a magniﬁ  ed view of the boxed area).HOW LOSS OF APC LEADS TO POLYPLOIDY • DIKOVSKAYA ET AL. 191
Discussion
Tetraploidy has been correlated with poor cancer prognosis 
(Ladenstein et al., 2001; Sudbo et al., 2001; Melegh et al., 
2005). Recent evidence suggests that it is not just a harm-
less side effect of cancer-promoting chromosomal instability 
but could be tumorigenic in its own right (Fujiwara et al., 
2005). Thus, it is important to understand the mechanisms 
  involved in producing and maintaining tetraploidy in cancer 
and the mechanisms that normally prevent cells from becom-
ing tetraploid.
In this study, we show that depletion of the APC tumor 
suppressor is suffi  cient to produce tetraploidy. Our data are 
consistent with the idea that this occurs, at least in part, via 
mitotic slippage with nonseparated chromosomes. When cells 
divide, the spindle checkpoint machinery ensures that all 
kinetochores are attached to spindle microtubules and are under 
tension. When this process is completed, the anaphase-
  pro  moting complex is activated to initiate a proteolytic cascade 
that, on one hand, results in chromosome separation because of 
the release of separase and, on the other hand, initiates mitotic 
exit that begins with inactivation of the CDK1–cyclin B complex 
and leads to cytokinesis (Cleveland et al., 2003; Castro et al., 
2005). If the mitotic checkpoint cannot be satisfi  ed because of 
spindle damage, cells arrest at this stage for a limited length 
of time that depends on many factors and varies between cell 
types (Rieder and Maiato, 2004). At this point, cells are either 
cleared by apoptosis or escape mitotic arrest to reenter G1 with 
a 4n DNA content. Our live imaging data (Fig. 4) suggest that 
in the absence of APC, the second route for mitotic exit dom-
inates. In U2OS cells depleted of APC by RNAi, 85% of cells 
that exited a taxol-induced arrest spread again and remained 
alive. Although U2OS cells have a relatively high spontaneous 
slippage rate, this number was more than doubled when APC 
was removed.
At this time, we do not understand the mechanism of 
  mitotic slippage well enough to clearly dissect the role of APC 
in this process. However, there are several clues. First, we 
show that the mitotic spindle checkpoint is compromised after 
APC removal. Mitotic progression of logarithmically grown 
cells was faster despite spindle damage induced by APC loss 
(Fig. 1), and mitotic checkpoint proteins Bub1 and BubR1 
were not localized effi  ciently to the kinetochores. Importantly, 
the accelerated exit from drug-induced mitotic arrest in APC-
 defi  cient cells refl  ects a defect in this checkpoint (Figs. 1 and 4). 
The reduced accumulation of Bub1 and BubR1 at kinetochores 
precedes and, thus, might be the cause of premature mitotic 
exit. Indeed, we found that the depletion of Bub1 by RNAi 
from U2OS cells caused a similar decrease in mitotic arrest as 
the depletion of APC (unpublished data). However, it is also 
formally possible that these events occur independently of 
each other. Experiments from another laboratory did not re-
veal a mitotic checkpoint defect in APC-depleted HeLa cells 
(Draviam et al., 2006). This discrepancy is likely caused by dif-
ferences in the experimental approach used to measure such 
defects. Our experimental setup was able to detect a compro-
mised mitotic checkpoint, whereas that used by Draviam et al. 
(2006) was designed to only detect the complete absence of a 
mitotic checkpoint.
Second, we observed extensive degradation of cyclin B1 
in these cells after prolonged mitotic arrest. Of course, this 
could be a consequence of the mitotic checkpoint defect, as its 
abrogation would induce the cyclosome-driven degradation of 
cyclin B as cells exit mitosis. On the other hand, the destruction 
of cyclin B was previously reported to accompany mitotic slip-
page in mammalian cells with an active mitotic checkpoint 
(Jablonski et al., 1998). At this point, we cannot distinguish 
whether increased cyclin B degradation in APC-defi  cient cells 
is a cause or a consequence of premature mitotic exit.
Third, the failure of APC-defi  cient cells to die after they 
had escaped mitotic arrest could be related to the decreased 
apoptosis we detected in all APC-negative cells (Fig. 5). 
Bax-dependent apoptosis can be induced by mitotic slippage 
after prolonged mitotic arrest; however, this requires an intact 
mitotic checkpoint (Tao et al., 2005). Thus, apoptosis defi  ciency 
of APC-negative cells could be partially related to the mitotic 
checkpoint defect in these cells. However, this can only be 
part of the story because we detect a decreased rate of apop-
tosis in the absence of APC even in cells that were not 
  exposed to mitotic poisons. An alternative explanation places 
both apoptotic and mitotic checkpoint defects downstream of 
one event, namely Bub1/BubR1 insuffi  ciency. The proapop-
totic function of the mitotic checkpoint proteins BubR1 and 
Bub1 (kinetochore-associated pools of both of them are 
 decreased  in  APC-defi  cient cells) can trigger apoptosis specifi  -
cally in polyploid cells (Shin et al., 2003). It is possible that 
a defect in this function of Bub1 and BubR1 in APC-depleted 
cells is responsible for their inability to undergo apoptosis 
effi  ciently. Consistent with this idea, the relative number of 
polyploid cells is overproportionally increased in APC-neg-
ative cultures (Fig. 6 B). Importantly, overexpressing recom-
binant Bub1 reduced polyploidy that was induced by APC 
loss and rendered the mitotic spindle checkpoint less sensi-
tive to APC inhibition (Fig. S4, available at http://www.jcb.
org/cgi/content/full/jcb.200610099/DC1).
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In this context, it is important to note that we found 
  decreased apoptosis in all of the APC-defi  cient systems we tested, 
including fi  broblasts with a fl  oxed APC allele that allows the 
conditional inactivation of APC (Fig. S1). These particular cells 
lack a functional mitotic checkpoint; both fl  oxed fi  broblasts and 
their wild-type counterparts did not maintain a mitotic arrest 
when treated with mitotic poisons (unpublished data). Interest-
ingly, in these cells, only Bub1 but not BubR1 was reduced at 
the kinetochores when the APC level was reduced. Thus, the 
apoptotic defect in these cells could not be mediated by changes 
in BubR1. Importantly, data from these cells suggest that the 
downregulation of Bub1 at kinetochores is a primary conse-
quence of APC loss and that the lack of BubR1 in the two other 
cell types may be secondary to the Bub1 defi  ciency. Indeed, 
BubR1 was shown to require Bub1 to be recruited to kineto-
chores (Johnson et al., 2004).
APC is a known negative regulator of the Wnt pathway. 
To determine whether this function contributes to the effect of 
APC on ploidy, we used HCT116 cells as a model. These cells 
have constitutively active β-catenin that is insensitive to APC 
depletion. Using these cells, we showed that APC is likely to 
  affect the mitotic checkpoint and apoptosis independently of 
β-catenin targets (Fig. 7). This is in contrast to recent data 
that implicate the upregulation of conductin downstream of 
 activated  β-catenin in establishing genomic instability in the 
absence of APC (Hadjihannas et al., 2006). However, activation 
of Wnt signaling by APC inhibition in HCT116 cells used 
in this study was not well described, making a direct compari-
son diffi  cult.
Our current data are consistent with the idea that the effect 
of APC on the spindle checkpoint and possibly on apoptosis in-
volves Bub1 and, in some cases, BubR1. Recently, caspases 
were implicated in the removal of Bub1 and BubR1 from kineto-
chores during prolonged mitotic arrest and the resulting 
mitotic slippage (Baek et al., 2005). Because APC is found at 
kinetochores (Fodde et al., 2001; Kaplan et al., 2001), where 
many spindle checkpoint components accumulate, we consid-
ered the possibility that APC could protect checkpoint proteins 
from degradation by caspases at these sites. However, the defect 
in mitotic arrest induced by APC depletion was not altered by 
caspase inhibitors (unpublished data), suggesting that this is not 
the case. Furthermore, the removal of APC did not alter the 
phosphorylation of Bub1 and BubR1 in mitotically arrested 
cells (unpublished data). Therefore, the molecular mechanism 
of Bub1 and/or BubR1 regulation by APC remains unresolved.
The combination of spindle, spindle checkpoint, and 
apoptosis defects allows APC-negative cells in culture to be-
come polyploid. Importantly, our data are supported by 
in vivo evidence showing that the inhibition of APC in intestinal 
mouse epithelia also leads to the loss of euploidy 3 d after APC 
loss is induced. It is intriguing that in this case, both prominent 
tetraploidy and a decrease in the number of apoptotic bodies in 
intestinal crypts (relative to increased apoptosis in the rest of 
the tissue; unpublished data) were restricted to the same area 
of the epithelium. Furthermore, a section of intestine from an 
APC
min mouse that produces β-catenin–positive adenomas 
(Fig. 8 I) after the loss of wild-type APC also revealed a 
striking difference in the nuclear size between cells in small 
β-catenin–positive lesions and the surrounding APC heterozygous 
(APC
wt/min) normal tissue. Consistent with the idea that the mi-
totic checkpoint is compromised in the absence of APC, APC-
Min mouse adenomas were arrested in mitosis by vinorelbine 
treatment less effi  ciently than normal tissues in these mice (our 
preliminary data).
In summary, we show that the loss of APC has immediate 
consequences: spindle defects together with a compromised mi-
totic checkpoint can produce tetraploid cells; combined with 
decreased apoptosis, this promotes the expansion of the poly-
ploid population (Fig. 9). Furthermore, we demonstrate the loss 
of euploidy in the mouse gut after the inactivation of APC and 
in adenomas from Min mice, suggesting that tetraploidy is 
  indeed a common feature of APC-defi  cient cancers.
Lack of APC induces a spectrum of cell cycle defects 
that can amplify each other to promote genetic instability. 
  Furthermore, in the context of deregulated β-catenin, which 
maintains cells in a proliferative state inappropriately, the re-
sulting defects in genetic stability could be particularly effective 
in producing tumors.
Materials and methods
Cell culture and treatment
Human colon carcinoma HCT116 cells and mouse embryonic ﬁ  broblasts 
constitutively deﬁ  cient or wild type for APC (a gift from R.A. Weinberg, 
Whitehead Institute, Cambridge, MA) were cultured in DME supplemented 
with 10% FCS and 1% penicillin-streptavidin stock solution (MP Biomedi-
cals). For human osteosarcoma U2OS cells, nonessential amino acids 
(1:100; Sigma-Aldrich) and 1% L-glutamine were added.
For siRNA-mediated inhibition, U2OS cells were transfected using 
siPORT-NeoFX reagent (Ambion) according to the manufacturer’s instruc-
tions with 5 nM of either siRNA-targeting human APC (SmartPool reagent; 
Dharmacon) or nontargeting siCONTROL siRNA (Dharmacon) and were 
grown for 2–3 d. Alternatively, transfection with 16.7 nM siRNA using 
  OligofectAMINE transfection reagent (Invitrogen) gave a similar level 
and timing of APC inhibition. For time-lapse imaging, U2OS cells were 
  cotransfected with 0.2 μg H2B-RFP (a gift from M. Posch, Dundee Univer-
sity, Dundee, UK) together with 12.5 nM of appropriate siRNA (Dharmacon) 
using LipofectAMINE 2000 reagent (Invitrogen) according to the 
manufacturer’s instructions. In HCT116 cells, APC was inhibited by trans-
fection for 2 d consecutively with 50 nM of control or APC-targeting siRNA 
(Dharmacon) using OligofectAMINE and were allowed to grow for 
another day.
For mitotic arrest, U2OS cells were treated with the indicated 
amount of nocodazole or taxol for 20 h (unless stated otherwise), and 
HCT116 cells were treated with 10 ng/ml taxol or 100 ng/ml nocodazole 
for 12 h. For synchronization, U2OS cells received two rounds of 2 mM 
thymidine for 22 h with a 10-h interval. When needed, 1.25 μg/ml taxol 
or nocodazole was added at the time of release from the second thymidine 
block. For time-lapse imaging of mitotic progression (Fig. 1), U2OS cells 
were presynchronized with a single 18-h thymidine treatment and were re-
leased 6 h before taking images to enrich for cells dividing at the time of 
ﬁ  lming. For apoptosis induction, cells were treated with 0.1 μM staurospo-
rine (Calbiochem) for 12 h before analysis.
Immunoﬂ  uorescence
Cells were ﬁ  xed in warm 1.85% PFA in PHEM buffer (60 mM Pipes, 4 mM 
MgSO4, 25 mM Hepes, and 10 mM K-EGTA, pH 6.9) for 15 min, washed 
in PBS, and blocked in blocking buffer containing 0.1% Triton X-100, 2% 
BSA, 5% donkey serum, and 0.02% NaN3 in PBS supplemented with 50 
mM NH4Cl for at least 15 min. Alternatively, cells were ﬁ  xed in ice-cold 
methanol for 5 min, rehydrated in PBS, and blocked in the aforementioned 
blocking buffer for at least 30 min. Primary antibodies were diluted in 
blocking buffer as follows: anti-Bub1 and -BubR1 (gift from S. Taylor, Uni-
versity of Manchester, Manchester, UK) were used at 1:130 for mouse cell 
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used at 1:500, and CREST was used at 1:100 for mouse cell lines and at 
1:300 for human cell lines (gift from B. McStay [Biomedical Research Cen-
tre, Ninewells Hospital, Dundee, Dundee, UK] and W. Earnshaw [Univer-
sity of Edinburgh, Edinburgh, UK]). Secondary antibodies raised in donkey 
(Jackson ImmunoResearch Laboratories) conjugated with either FITC, Texas 
red, or Cy5 were used at a 1:250 dilution. Cells were counterstained with 
DAPI at 1 μg/ml for 2 min.
Microscopy
High resolution images were collected with an imaging system (Delta-
Vision Restoration; Applied Precision) built on an inverted microscope or 
stand (Eclipse TE200; Nikon; or 1X70; Olympus) using a 100× NA 1.4 
objective lens. Images were acquired at 0.2-μm intervals in the z dimen-
sion and were deconvolved, and, where required, projections of multiple 
sections were built using SoftWoRx software (Applied Precision). Interki-
netochore distances were measured in 3D images using SoftWoRx. H2B 
ﬂ  uorescence/brightﬁ  eld time lapses were acquired on a DeltaVision Resto-
ration imaging system that was built on a stand (1X70; Olympus) equipped 
with a 37°C chamber using a 40× NA 1.4 dry objective lens. We col-
lected ﬁ  ve ﬂ  uorescent sections at 2-μm intervals in the z dimension and 
one brightﬁ  eld reference image in the middle of the stack every 10 min for 
19 h for mitotically arrested U2OS cells or every 3 min for 6 h for the mi-
totic progression of logarithmically grown U2OS cells. Fluorescent H2B 
projections were built from the sections containing in-focus images using 
SoftWoRx software.
Analysis of images to measure the amount of Bub1 and BubR1 
at kinetochores
Deconvolved 3D images of cells stained for CREST (kinetochore marker) 
and either Bub1, BubR1, or both were cropped around the nuclear area 
using SoftWoRx Explorer (Applied Precision) and analyzed in an open 
source microscopy image management system (Open Microscopy Environ-
ment [OME]; Swedlow et al., 2003; Goldberg et al., 2005; Hogan, 
2005). The FindSpots algorithm available within OME was used to auto-
matically analyze entire datasets of images. This algorithm identiﬁ  ed as 
  kinetochores any 3D objects with a volume of >30 voxels and intensities 
of CREST staining above the threshold, which was set up as μ + nσ, where 
μ is the mean, σ is the standard deviation of all voxels in the image stack, 
and n is either three or four but is constant throughout each experiment. 
The total Bub1 or BubR1 kinetochore intensity in each cell was determined 
by adding the integrated intensity of Bub1 or BubR1 signal for all 3D ob-
jects deﬁ  ned by the thresholded CREST signal in the image. After subtract-
ing the background, which was calculated as Vk × μBub, where μBub is the 
mean voxel intensity in the Bub1 or BubR1 channel and Vk is the total 
CREST-positive (kinetochore) volume of that image, this ﬁ  gure was stan-
dardized using the total kinetochore volume to yield a background-
  corrected kinetochore-speciﬁ  c intensity: K*bub = (KBub − Vk × μBub)/Vk.
This analysis was achieved through mostly automated data process-
ing, which facilitated the analysis of a large number of images (Schiffmann 
et al., 2006). The data was summarized visually using box and whisker 
plots. Each shows the normalized per cell kinetochore levels of Bub1 or 
BubR1 through a ﬁ  ve-point summary: the median (thick middle line), lower 
quartile (bottom boundary of box), upper quartile (top boundary of box), 
and the lower and upper extents of the data (bottom and top whiskers 
drawn from the box, respectively). This occurred after excluding outliers as 
deﬁ  ned by the standard 1.5 interquartile range (IQR) rule: mild outliers 
were deﬁ  ned as those points lying >1.5 times the IQR away from the lower 
or upper quartiles and are indicated by small circles; extreme outliers (ly-
ing more than three times the IQR) are shown by asterisks (Fig. 2). Box 
plots were generated using SPSS software version 11 (SPSS, Inc.). Two-
tailed t tests were performed using the Analysis ToolPak in Excel 2004 (Mi-
crosoft) to determine whether there was a statistically signiﬁ  cant difference 
in the mean of the kinetochore intensities after removing the outliers identi-
ﬁ  ed by SPSS. Alternatively, t tests and Mann-Whitney rank sum tests were 
performed using the SigmaSTAT program (Systat Software, Inc.).
Western blots
Cells were lysed in MEBC buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 
5 mM EGTA, 5 mM EDTA, 0.5% NP-40, and 40 mM β-glycerol phos-
phate) supplemented with 10 μg/ml each of leuptin, pepstatin A, and 
chymotrypsin. Soluble fractions were run on 4–12% gradient SDS gels (In-
vitrogen) using MOPS running buffer and transferred to nitrocellulose mem-
brane (Protran) with a 0.1-μm pore size (Schleicher & Schuell). For APC 
detection, Ali mouse monoclonal antibody (against N terminus; Cancer 
Research UK; Efstathiou et al., 1998) or crude serum of rabbit polyclonal 
antibody raised against the middle portion of APC (anti-APCII; Nathke 
et al., 1996) were used at 1:1,000 in blocking solution (TBS containing 5% 
nonfat milk, 1% donkey serum, and 0.02% Triton X-100). Anti–α-tubulin 
mouse monoclonal antibody DM1a (Sigma-Aldrich) was used at a dilution 
of 1:2,000, anti-actin (C4 clone; MP Biomedicals) was used at 1:2,000, 
anti–glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Abcam) was 
used at 1:5,000, anti-Bub1 and -BubR1 sheep polyclonal antibodies 
(gifts from S. Taylor) were diluted 1:500, and anti–β-catenin polyclonal 
antibody against C terminus (Hinck et al., 1994) was diluted 1:1,000. 
  Secondary anti–rabbit, –mouse or –sheep HRP-labeled antibodies (Scottish 
Antibody Production Unit) or IRDye 800/700–conjugated anti–sheep and 
–mouse secondary antibodies (either Invitrogen or Rockland) were used at 
1:5,000 dilutions.
Flow cytometry
For mitotic index measurements, cells were collected and ﬁ  xed in 1% PFA 
in PBS at 37°C for 20 min, washed in PBS, and postﬁ  xed and permeabi-
lized in 70% ethanol at −20°C for >30 min before staining with phospho-
histone H3 antibodies (Upstate Biotechnology) diluted to 10 μg/ml in PBS 
with 1% BSA followed by AlexaFluor488-labeled anti–rabbit secondary 
antibody (Invitrogen) at a 1:150 dilution in PBS with 1% BSA. This was fol-
lowed by 50 μg/ml propidium iodide in PBS containing 50 μg/ml RNase 
A and 0.1% Triton X-100. Alternatively, cells were stained with FITC-
  labeled antiphosphohistone H3 antibody (Upstate Biotechnology) followed 
by staining with 20 μg/ml 7AAD in PBS for the DNA proﬁ  le. To measure 
G2/M or sub-G1 fractions, cells were collected, washed in 1% BSA in 
PBS, and ﬁ  xed/permeabilized in 70% ethanol at −20°C for >30 min 
  before staining with 50 μg/ml propidium iodide in PBS containing 50 μg/ml 
RNase A and 0.1% Triton X-100. For identiﬁ  cation of early tetraploid cells, 
cells were ﬁ  xed in 70% EtOH at −20°C, permeabilized on ice for 5 min in 
PBS containing 1% BSA and 0.25% Triton X-100, and stained with FITC-
conjugated anti–cyclin B1 antibody or FITC-conjugated isotype control an-
tibody (BD Biosciences) followed by staining with 20 μg/ml 7AAD in PBS. 
The cell proﬁ  le was analyzed on a ﬂ  ow cytometer (FACSCalibur; Becton 
Dickinson) using CellQuest Pro software (BD Biosciences). Alternative data 
analysis was performed using Flowjo software (Tree Star, Inc.). In any kind 
of DNA proﬁ  le analysis, clusters of two or more cells were excluded from 
analysis by gating. The cyclin B1–negative population was deﬁ  ned using 
the proﬁ  le obtained with a FITC-labeled isotype control antibody combined 
with 7AAD. For active caspase 3 staining, cells were ﬁ  xed and stained us-
ing the active caspase 3 phycoerythrin (PE) monoclonal antibody apopto-
sis kit (BD Biosciences) according to the manufacturer’s instructions.
To determine DNA content in the mouse intestine, cells were extracted 
from the top 10 cm of the mouse small intestine. Intestines were opened, 
and the epithelium was removed with a scalpel blade. Cells were sus-
pended in 1 ml of detergent solution (0.1 mol/ml citric acid and 0.5% 
vol/vol Tween 20), gently shaken for 20 min at room temperature, and 
passed through a 100-μm sieve. DRAQ5 (deep red anthraquinone; Biosta-
tus) was added to a concentration of 20 μM before the detection of DNA 
content on a ﬂ  ow cytometry system (FACSVantage; Becton Dickinson).
Induction of APC loss in mice, immunocytochemistry, and determination 
of nuclear area
To induce recombination, AchCre
+APC
ﬂ  /ﬂ   and AchCre
+APC
wt/wt mice   
(Sansom et al., 2004) were given either single or multiple intraperitoneal 
injections of 80 mg/kg β-napthoﬂ  avone. At each time point, mice were 
killed, and the small intestine was removed and ﬂ  ushed with water. The 
proximal 10 cm of intestines was divided into 1-cm lengths, bundled using 
surgical tape, and ﬁ  xed in 4% formaldehyde at 4°C for no more than 
24 h before processing.
Immunohistochemistry of mouse intestines was performed using two 
different antibodies for p21, which gave the same pattern of expression 
(1:5, Neomarkers; and 1:25, Santa Cruz Biotechnology, Inc.). Nuclear 
area was assessed using standard protocols (Nunez et al., 2000) after 
  image capture with analySIS software (Soft Imaging Systems). Immunohisto-
chemistry with β-catenin antibody (dilution of 1:50; Becton Dickinson) on 
a small intestine of an APC
min mouse (Moser et al., 1990) was performed 
as described previously (Sansom et al., 2004).
Online supplemental material
Fig. S1 shows analysis of mitotic and apoptotic defects caused by APC 
  reduction in mouse ﬁ  broblasts with conditional APC expression. Fig. S2 pre-
s  ents a comparison of cell cycle and G2 progression of presynchronized 
APC-negative and control U2OS. Fig. S3 shows comparative activation of 
the β-catenin/TCF-responsive promoter by APC depletion in U2OS and JCB • VOLUME 176 • NUMBER 2 • 2007  194
HCT116 cells. Fig. S4 shows the rescue effects of recombinant Bub1 over-
expression in U2OS cells on mitotic checkpoint damage and polyploidy 
induced by APC depletion. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200610099/DC1.
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